Certain protease-digested lactoferrin fragments were found to exhibit improved therapeutic activities (Gifford et al., 2005), where our recent research found that protease-digested recombinantly expressed full-length human lactoferrin (flHLF) showed improved anti-cancer properties (Pan et al., 2021). This evidence concerns the gene LTF and cancer.